Cumberland Pharmaceuticals (CPIX) Long-Term Deferred Tax (2010 - 2020)

Cumberland Pharmaceuticals has disclosed Long-Term Deferred Tax across 10 years of filings, most recently posting $21802.0 for Q3 2020.

• Long-Term Deferred Tax for Q3 2020 came in at $21802.0, down 50.0% year-over-year; the trailing twelve-month figure through Sep 2020 was $21802.0 (down 50.0% YoY), and the FY2019 annual result was $21802.0, down 75.0% from the prior year.
• Long-Term Deferred Tax came in at $21802.0 for Q3 2020 at Cumberland Pharmaceuticals, roughly flat from $21802.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $3.5 million in Q1 2017 to a low of $21802.0 in Q4 2019.
• The 5-year median for Long-Term Deferred Tax is $65407.5 (2017), against an average of $523162.6.
• Peak annual rise in Long-Term Deferred Tax reached 0.0% in 2018, while the deepest fall reached 97.53% in 2018.
• Cumberland Pharmaceuticals' Long-Term Deferred Tax stood at $3.1 million in 2016, then slumped by 97.2% to $87210.0 in 2017, then changed by 0.0% to $87210.0 in 2018, then tumbled by 75.0% to $21802.0 in 2019, then changed by 0.0% to $21802.0 in 2020.
• The last three Long-Term Deferred Tax figures came in at $21802.0 (Q3 2020), $21802.0 (Q2 2020), and $21802.0 (Q1 2020), per Business Quant data.